Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2015
Source ID
10.1016/s0140-6736(15)61117-5

Entities

People

  • Aboubacar Soumah
  • Ana María Henao-restrepo
  • Andrea S Vicari
  • Anton Camacho
  • Bertrand Draguez
  • Conall H Watson
  • Eeva Kuisma
  • Godwin Enwere
  • Gunnstein Norheim
  • Ira M. Longini
  • John-arne Røttingen
  • Mandy Kader Kondé
  • Marie Paule Kieny
  • Matthias Egger
  • Miles W. Carroll
  • Moussa Doumbia
  • Myron M. Levine
  • Natalie E Dean
  • Rebecca Grais
  • Sakoba Kéïta
  • Sema Mandal
  • Sophie Duraffour
  • Souleymane Kone
  • Stefanie Hossmann
  • Stephan Gunther
  • Sven Trelle
  • W John Edmunds
  • Ximena Riveros

Organizations

  • Canadian Institutes of Health Research
  • Department for International Development
  • Doctors Without Borders
  • European Commission
  • Gates Foundation
  • Health Canada
  • International Development Research Centre
  • Ministry of Foreign Affairs of Norway
  • Public Health Agency of Canada
  • Research Council of Norway
  • United States Department of Defense
  • Wellcome Trust
  • World Health Organization
  • foreign affairs ministry

Tags

Technology Areas

  • Biotechnology